Concourse Financial Group Securities’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Hold
0
8115
2018
Q3
Hold
0
7913